All News

Merck this week notified the FDA that it will stop selling its Victrelis medicine in the US by the end of this year, although the drug will remain available in other countries.

A major technical partner is announced for the long-awaited HIT initiative that will give oncologists a data-derived "second opinion" right from their desktops, with the earliest versions scheduled to come online this year.

Karyl Blaseg, RN, MS, OCN, writes about the important role of patient navigators in preventing healthcare disparities and promoting patient-centered care among cancer patients.

The Office of the National Coordinator for Health Information Technology has created the new position of chief health information officer, which will be filled by Michael James McCoy, MD.

Existing cancer therapies are geared toward massacring tumor cells, but researchers propose a different strategy: subtly hardening cancer cells to prevent them from invading new areas of the body. They devised a way of screening compounds for the desired effect and have identified a compound that shows promise in fighting pancreatic cancer.

The meta-analysis published today and an accompanying editorial should serve as a wake-up call for healthcare organizations about the costs of caring for aging populations that have spent much of their lives behind desks and watching TV.

Working collaboratively leads to more accurate diagnoses and may help reduce medical errors, according to a study published in JAMA.

In it's report, "Clinical Cancer Advances 2015: ASCO's Annual Report on Progress Against Cancer," published in the Journal of Clinical Oncology, 4 newly approved treatments for CLL were predicted to have a dramatic impact on patients with the disease.

A little-known side to the government's health insurance website is prompting renewed concerns about privacy, just as the White House is calling for stronger cybersecurity protections for consumers.

The study conducted at the Michigan Center for Translational Pathology studied IncRNAs and their role in cancer.

Although the healthcare sector will hire at a faster pace in 2015, the outlook for growth in hospital employment is modest, at best.

When discharge summaries contain detailed information and are sent quickly to primary care physicians, they can help reduce hospital readmissions, according to studies from researchers at Yale School of Medicine.

The CEO of Kite Pharma plans to initiate early conversations with insurers, even before the launch of a clinical trial of their experimental drug, to ensure smooth sailing once the product is approved and launched.

Researchers at the University of Maryland are evaluating the value of a person's spit to screen for lung cancer, replacing the traditional and recently recommended CT scan.

A new pay-for-performance method would adjust payments in such a way that providers would not be discouraged from caring for disadvantaged patients, according to researchers at RAND.

US healthcare executives say that despite repeated calls from Republican lawmakers for repeal of President Obama's healthcare law, the Affordable Care Act is too entrenched to be removed.

A study published in Clinical Cancer Research found that 33% of lung cancer biopsies evaluated had a gain of function amplification in the MET receptor tyrosine kinase.

Since Express Scripts announced its exclusivity agreement with AbbVie for its hepatitis C drug, other pharmacy benefits managers and insurers have picked sides. But are the deals a good thing?

A new study on the effects of cancer patients' financial burdens suggests that pharmacists can play a role in easing or preventing some of their stress.

The tentative agreement, which must be ratified by 18,000 RNs, calls for a 14% raise over 3 years and retirement protections, as well as safety steps including training to prevent nurses from being harmed by infectious diseases such as Ebola.

Until recently, many experts thought that a clinician could literally pick any antidepressant or type of psychotherapy at random because, with a few clinical exceptions, there was little evidence to favor one treatment over another for a given patient.

Although more than 70% of physicians use electronic health records, up to half don't routinely receive the patient information needed to coordinate care effectively.

Discussions of innovation in healthcare often focus on new technologies, big data, and refined population health strategies within the context of mature Western healthcare systems.

Patients increasingly are looking for healthcare providers that offer digital services, but many still fail to do so.

Obama administration officials have warned that ambitious experiments run by the health law's $10 billion innovation lab wouldn't always be successful. Now there is evidence their caution was well placed.

Population health management programs are paying off, according to a survey of healthcare managers. More than half of respondents expect to recoup investments into these programs within 3 to 4 years, KPMG LLP found.

For years, one prescription to healthcare woes in the United States has been to shift costs to consumers, on the theory that this will cause them to make more cost-effective decisions. As this experiment plays out in real life, however, a different reality is unfolding.

Medicare payments for hospice care carried out in an assisted living facility more than doubled from 2007 to 2012, raising questions about the incentives that Medicare provides for hospice care.

Covered California's leader says its decision is only fair to those insurers who took on the risk of a brand new marketplace in 2014. But the state's insurance commissioner says limiting choices is unfair to consumers.

Researchers have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage.